Company Filing History:
Years Active: 2008-2009
Title: Innovator Spotlight: Kory Johnson
Introduction
Kory Johnson, a notable inventor based in Gaithersburg, MD, has made significant strides in the field of biotechnology. With a total of five patents to his name, Johnson's work focuses primarily on the identification of toxicity markers and the assessment of hepatotoxicity associated with pharmaceutical compounds. His innovative approaches have broad implications for drug screening and safety evaluation.
Latest Patents
Among Kory Johnson’s most recent patents are essential methodologies for determining hepatotoxins. The present invention elaborates on global changes in gene expression, providing a framework for identifying toxicity markers within tissues or cells that are exposed to known toxins. These toxicological markers are instrumental in drug screening processes and toxicity assays. Additionally, his patents include a comprehensive database of genes that exhibit toxin-induced differential expression, specifically designed for use with microarrays and other solid-phase probes.
Career Highlights
Throughout his career, Kory Johnson has been a valuable asset at Ocimum Biosolutions, Inc., contributing to the advancement of biotechnology research and innovations. His work has led to patents that underscore his commitment to improving drug safety. Johnson’s findings have paved the way for enhanced methodologies that ensure pharmaceuticals are thoroughly evaluated before reaching the market.
Collaborations
Kory Johnson works alongside distinguished colleagues, including Donna Mendrick and Mark Porter, who are also prominent figures in the field. Their collaborative efforts have fostered a dynamic research environment that emphasizes the importance of teamwork in developing ground-breaking technologies and innovations in toxicity assessment.
Conclusion
Kory Johnson's contributions to biotechnology through his patents highlight his role as an influential inventor in the realm of drug safety and toxicity. His ongoing innovations signify a commitment to improving methodologies vital for public health. As the landscape of pharmaceutical development continues to evolve, Johnson's work remains at the forefront of ensuring safer therapeutic options for consumers.